Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Value-Based Cancer Care

- PMLiVE

Standard steroid improves recovery of critically-ill COVID-19 patients

The study evaluated hydrocortisone in 403 patients with suspected or confirmed COVID-19

Live webinar from Singapore

Digital #marcomms: How to evaluate and optimise marketing activities impacted by COVID-19

Inizio

- PMLiVE

OPEN Health’s virtual reflections on the World Orphan Drug Congress US

Another congress attended in this virtual world with learnings gathered and connections made across the rare disease community. It was great to be joined by many colleagues from all our...

OPEN Health

Roche Basel Switzerland

Roche plans to launch rapid COVID-19 antigen test later this month

Swiss pharma also intends to file for emergency approval in the US

AstraZeneca AZ

AZ’s Farxiga cuts risk of death in chronic kidney disease

Detailed results revealed at the European Society of Cardiology virtual congress

Guide

UX research

Inizio

Article: Why pharma must trust the science of behaviour

In a recent interview with PME Magazine, Dan Coffin, Director explains why the application of behavioural science will be key to better health far beyond COVID-19.Read the full article here:...

Inizio

Case study

Using qualitative conjoint to assess willingness-to-pay

Inizio

- PMLiVE

Nestlé is set to acquire Aimmune in deal worth $2.6bn

Aimmune’s Palforzia therapy is the only FDA-approved peanut allergy drug

EU flag

EU to contribute €400m to WHO’s COVID-19 vaccine facility

Contribution will go towards ensuring equitable access to COVID-19 vaccines

Top 10 Tips for “Virtualizing” In-person Meetings

With over 11 years of experience in virtualizing meetings in the life science industry, Impetus Digital has a wealth of experience and knowledge to share.

Impetus Digital

- PMLiVE

Exploiting the value of data in pharma

How using data in an agile way can dramatically accelerate innovation and clinical trials

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links